Hexafluorenium bromide - CAS 317-52-2
Catalog number:
317-52-2
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C36H42N2.2Br
Molecular Weight:
662.54008
COA:
Inquire
Targets:
Others
Description:
Hexafluronium bromide is .a cholinesterase inhibitor used in anesthesiology to prolong and potentiate the skeletal muscle relaxing action of suxamethonium during surgery
Publictions citing BOC Sciences Products
  • >> More
Purity:
≥98%
Appearance:
Solid powder
Synonyms:
Mylaxen; 9H-fluoren-9-yl-[6-[9H-fluoren-9-yl(dimethyl)azaniumyl]hexyl]-dimethylazanium;dibromide;
Solubility:
Soluble in DMSO
Storage:
Store at -20 °C
MSDS:
Inquire
Application:
Acetylcholine Receptor
Quality Standard:
Enterprise standard
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly.
Quantity:
Milligrams-Grams
InChIKey:
WDEFPRUEZRUYNW-UHFFFAOYSA-L
InChI:
1S/C36H42N2.2BrH/c1-37(2,35-31-21-11-7-17-27(31)28-18-8-12-22-32(28)35)25-15-5-6-16-26-38(3,4)36-33-23-13-9-19-29(33)30-20-10-14-24-34(30)36;;/h7-14,17-24,35-36H,5-6,15-16,25-26H2,1-4H3;2*1H/q+2;;/p-2
Canonical SMILES:
C[N+](C)(CCCCCC[N+](C)(C)C1C2=CC=CC=C2C3=CC=CC=C13)C4C5=CC=CC=C5C6=CC=CC=C46.[Br-].[Br-]
1.Synergistic effect of acidosis and succinylcholine-induced hyperkalemia in spinal cord transected rats.
Koller ME, Breivik H, Greider P, Jones DJ, Smith RB. Acta Anaesthesiol Scand. 1984 Feb;28(1):87-90.
The effects of spinal cord transection and acidosis on succinylcholine (SCC)-induced hyperkalemia were studied in Sprague-Dawley rats. The effectiveness of pretreatment with subparalyzing doses ("self-taming") of SCC or with the cholinesterase inhibitor hexafluorenium bromide in preventing hyperkalemia was also studied. The increase in plasma potassium after administration of SCC (1 mg/kg) was found to be significantly increased 10 days after spinal cord transection. This potassium increase could not be prevented by pretreatment with either hexafluorenium (0.3 mg/kg) or subparalyzing doses (0.15 mg/kg) of SCC. Respiratory acidosis caused an increase in plasma K+ in both normal and in spinal cord transected rats. Acidosis had a synergistic effect on succinylcholine-induced hyperkalemia. These findings support the clinical practice of not using succinylcholine in patients at risk of having a pathological sensitivity to SCC. Furthermore, SCC may be especially dangerous when administered to patients who are acidotic.
2.In vivo reversal of depolarizing neuromuscular blockade.
Riker WF Jr1, Okamoto M, Artusio JF Jr. Arch Int Pharmacodyn Ther. 1995 Jul-Aug;330(1):90-101.
The antagonism of depolarizing blockers, principally succinylcholine and decamethonium, by tetraethyl- and tetrabutylammonium ions in an in vivo neuromuscular preparation in anesthetized cats is described; possible mechanisms for these effects are discussed. Tetraethyl- (50-100 mg/kg, i.v.) and tetrabutylammonium (1-5 mg/kg, i.v.) produced sharp reversals of 95-99% succinylcholine and decamethonium blocks. These reversals were effective and sustained at any point during the course of the blockades. Tetraethyl- or tetrabutylammonium, administered 2-3 min before succinylcholine or decamethonium, prevented blockade, an effect compatible with an earlier reported in vitro investigation. The studies of others disclose the interaction of depolarizing blockers with acetylcholine receptors, leading to channel opening, channel entry and binding therein of these blockers. The present studies support this in showing the prevention of succinylcholine and decamethonium block by the prior administration of tetraethylammonium, which also interacts with acetylcholine receptors.
3.Characterization of end-plate conductance in transected frog muscle: modification by drugs.
Lambert JJ, Durant NN, Reynolds LS, Volle RL, Henderson EG. J Pharmacol Exp Ther. 1981 Jan;216(1):62-9.
Cutaneous pectoris muscles of Rana pipiens were transected distal to the innervated region. Within 10 min, membrane potentials (Em's) of -33 +/- 2.5 mV and end-plate potentials (3-15 mV) were recorded unaccompanied by muscle action potentials or twitch. The fall in Em was associated with a net loss of [K+]i and a net gain of [Na+]i. Although input resistance fell by 50% and the space constant was slightly reduced in the transected muscle fibers, end-plates could be adequately voltage-clamped with two microelectrodes. End-plate currents (e.p.c.s) with rise times of 350 to 700 musec were recorded as a function of holding potential (Vm). The current-voltage relationship of peak e.p.c.s over the range of -70 to +20 mV was linear and the reversal potential (-6.6 +/- 2.2 mV) was the same as that found for intact muscle fibers. The decay phase of e.p.c.s could be described as a single exponential at all Vm's and had a voltage and temperature dependence similar to that described for e.
4.Bile salts and neuromuscular blocking agents.
Westra P, Houwertjes MC, Wesseling H, Meijer DK. Br J Anaesth. 1981 Apr;53(4):407-15.
The influence of the primary bile salts taurocholate and chenodeoxycholate on the neuromuscular blockade of the non-depolarizing drugs Org 6368, pancuronium, Org NC 45 and hexafluorenium was studied in cats. An increase in the effects of these agents, all possessing widely varying molecular structures, was found following administration of the bile salts. The bile salt concentrations in plasma were similar to those obtained after 9-10 days of extrahepatic cholestasis in cats. The effect of Org NC 45, a new monoquaternary analogue of pancuronium, was increased more than that of pancuronium. This increase in effect is probably a result of inhibition of the hepatic uptake of the neuromuscular blocking drugs. The neuromuscular blocking effect of gallamine was not influenced significantly by the administration of bile salts.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 858128-57-1 SPB

SPB
(CAS: 858128-57-1)

SPB is a key component of pulmonary surfactant which lowers surface tension in the lungs.

CAS 137-08-6 Calcium D-Panthotenate

Calcium D-Panthotenate
(CAS: 137-08-6)

Calcium D-Panthotenate, also called vitamin B5 Calcium, is a water-soluble vitamin and an essential nutrient for many animals.

CAS 154589-96-5 Stauprimide

Stauprimide
(CAS: 154589-96-5)

Stauprimide is an enhancer stem cell differentiation into endoderm. In vitro differentiation of embryonic stem cells is of great interest to regenerative medici...

CAS 300762-25-8 Hydrocarbon chain derivative 1

Hydrocarbon chain derivative 1
(CAS: 300762-25-8)

Hydrocarbon chain derivative 1 shows inhibitory effect on lipid synthesis (IC50= 11 μM).

CAS 483-63-6 Crotamiton

Crotamiton
(CAS: 483-63-6)

Crotamiton is a general antipruritic agent for treating scabies.

CAS 37921-38-3 Cimifugin

Cimifugin
(CAS: 37921-38-3)

Cimifugin is a major components of Yu-ping-feng-san, a Chinese medical formula that is used clinically for allergic diseases and characterized by reducing aller...

CAS 76150-91-9 TCPOBOP

TCPOBOP
(CAS: 76150-91-9)

TCPOBOP is an constitutive androstane receptor (mCAR) agonist with EC50 value of 20 nM. But it is effective for the mouse receptor but not for human or rat CAR ...

CAS 97759-16-5 S186

S186
(CAS: 97759-16-5)

S186 is a kind of sodium salts of calcium-acetylpropylamine phosphonate(APA). It is a new strontium-specific chelating agent. It has also been approved by Shang...

CAS 33996-33-7 Oxaceprol

Oxaceprol
(CAS: 33996-33-7)

Oxaceprol derived from L-proline, inhibiting inflammatory cell infiltration and bone damage in the adjuvant-injected paw.

CAS 129639-79-8 abafungin

abafungin
(CAS: 129639-79-8)

Abafungin is a broad-spectrum antifungal agent with a novel mechanism of action originated by York Pharma. In Aug 2009, Phase-III for Dermatomycoses in Japan an...

FR-190809
(CAS: 215589-63-2)

FR-190809 is a potent and orally efficacious ACAT inhibitor potentially for the treatment of Lipoprotein Disorders.

Systemin

Systemin is an 18-amino acid polypeptide isolated from tomato leaves, and is a powerful inducer of over 15 defensive genes.

NS-2214
(CAS: 171655-92-8)

NS-2214, an azabicyclo compound, has been found to be a dopamine uptake inhibitor that was once studied in the treatment of Parkinson's disease.

CAS 22494-42-4 Diflunisal

Diflunisal
(CAS: 22494-42-4)

Diflunisal, a salicylic acid derivative, is a non-steroidal anti-inflammatory drug with analgesic and anti-inflammatory activity.

CAS 33089-61-1 Amitraz

Amitraz
(CAS: 33089-61-1)

Amitraz is a non-systemic acaricide and insecticide, as an antiparasitic used to control red spider mites, leaf miners and scale insects.

CAS 40034-42-2 Rosoxacin

Rosoxacin
(CAS: 40034-42-2)

Rosoxacin. Rosoxacin is a 4-quinolone antibacterial with actions similar to those of nalidixic acid have antibacterial activity against Escherichia coli, Klebsi...

CAS 543-82-8 Octodrine

Octodrine
(CAS: 543-82-8)

Octodrine is a local anesthetic and vasoconstrictor, shows leucine aminotransferase inhibition.

CAS 57644-54-9 Gastrodenol

Gastrodenol
(CAS: 57644-54-9)

Gastrodenol is a mineral that is used in treating ulcers and upset stomach.

CAS 19992-50-8 ML329

ML329
(CAS: 19992-50-8)

ML329 is a small molecule MITF inhibitor that inhibits the expression of numerous micropthalmia-associated transcription factor (MITF) target genes and blocks t...

OT-R antagonist 1
(CAS: 364071-17-0)

OT-R antagonist 1 is a nonpeptide OT-R antagonist, inhibitis IP3-Synthesis, rat OT-R (IC50 = 8 nM).

Chemical Structure

CAS 317-52-2 Hexafluorenium bromide

Quick Inquiry

Verification code

Featured Items